ArticlePloS one2016

Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.

Noriaki Arakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.